Italy’s COVID-19 vaccine shows strong immune response in Phase II of clinical trials
Italy hopes to produce its own Covid-19 vaccine. Those hopes received a boost on Monday. Results from Phase II of the clinical trial by biotech firm ReiThera show a strong immune response and no major side effects.
Continue Reading